Announcement

Collapse
No announcement yet.

Tamiflu Resistant Pandemic H1N1 in Asymptomatic Traveler from San Francisco

Collapse
X
Collapse
 
  • Page of 2
  • Filter
  • Time
  • Show
Clear All
new posts
Previous 1 2 template Next
  • #1

    Tamiflu Resistant Pandemic H1N1 in Asymptomatic Traveler from San Francisco

    <TABLE dir=ltr border=1 cellSpacing=0 cellPadding=7 width=831><TBODY><TR><TD height=0 vAlign=top width="13%">98

    </TD><TD height=0 vAlign=top width="13%">F/36

    </TD><TD height=0 vAlign=top width="13%">Asymptomatic

    </TD><TD height=0 vAlign=top width="13%">Returned from San Francisco with mother and

    </TD><TD height=0 vAlign=top width="13%">Imported

    </TD><TD height=0 vAlign=top width="13%">Singapore Airlines(flight no SQ1) Arrived on June 11

    </TD><TD height=0 vAlign=top width="13%">Daughter (confirmed patient), mother, two sisters , a brother

    </TD><TD height=0 vAlign=top width="13%">Ping Tin Estate
    Kwun Tong


    </TD></TR></TBODY></TABLE>

    http://www.chp.gov.hk/files/pdf/PR_HSI_case_93_104.pdf
    Tags: None
  • #2
    Re: Tamiflu Resistant Pandemic H1N1 in Asymptomatic Traveler from San Francisco

    The above description matches the 16 year old patient from San Franciso who arrived in Hong Kong on June 11. The patient above was asymptomatic.

    Flight SQ1 is a direct flight from San Francisco to Hong Kong.

    Comment

    • #3
      Re: Tamiflu Resistant Pandemic H1N1 in Asymptomatic Traveler from San Francisco

      <TABLE class=tableBlue border=0 cellSpacing=0 cellPadding=0 width="100%"><TBODY><TR><TD colSpan=2>03rd July 2009 - Friday - Flight Number SQ1 / Aircraft (B777-300ER)

      </TD></TR><TR><TD colSpan=2><TABLE class=tableWhite width="100%"><TBODY><TR class=tableBlue><TD></TD><TD>Airport</TD><TD>Scheduled Time</TD><TD>Actual Time</TD><TD>Estimated Time</TD><TD>Status</TD></TR><TR><TD>Departure From </TD><TD>San Francisco (SFO) </TD><TD>01:05 (-1) </TD><TD>00:58 (-1) </TD><TD></TD><TD>Departed </TD></TR><TR><TD>Arrival In </TD><TD>Hong Kong (HKG) </TD><TD>06:35 </TD><TD>05:57 </TD><TD></TD><TD>Arrived </TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE>

      Comment

      • #4
        Re: Tamiflu Resistant Pandemic H1N1 in Asymptomatic Traveler from San Francisco

        Tin Ping Estate

        allocation_status
        http://www.housingauthority.gov.hk/en/interactivemap/estate/0,,1-347-1_4930,00.html

        Comment

        • #5
          Re: Tamiflu Resistant Pandemic H1N1 in Asymptomatic Traveler from San Francisco

          That flight has 349 seats total (42 FC, 307 econ).

          A singapore airlines flight (#1) arriving on the same day, is on a 77W.

          .
          "The next major advancement in the health of American people will be determined by what the individual is willing to do for himself"-- John Knowles, Former President of the Rockefeller Foundation

          Comment

          • #6
            Re: Tamiflu Resistant Pandemic H1N1 in Asymptomatic Traveler from San Francisco

            Based on the fact that the traveler "returned" to Hong Kong with her family and went to Hong Kong housing compex via public transportation suggest she is a Hong Kong resident.

            Comment

            • #7
              Re: Tamiflu Resistant Pandemic H1N1 in Asymptomatic Traveler from San Francisco

              <a rel="nofollow" href="http://www.recombinomics.com/News/07040901/H274Y_Asymptomatic.html">Commentary</a>

              Comment

              • #8
                Re: Tamiflu Resistant Pandemic H1N1 in Asymptomatic Traveler from San Francisco

                This case detected in Spain: a US military camp resident tested positive after returning from US; the patient was under antiviral since early this week; despite this, he needs to be hospitalized.

                Espana. Ingresa en la UCI un estadounidense de la base de Rota por gripe A ? ELPA?S.com - FluTrackers News and Information
                http://www.flutrackers.com/forum/showthread.php?t=114194

                Comment

                • #9
                  Re: Tamiflu Resistant Pandemic H1N1 in Asymptomatic Traveler from San Francisco

                  Originally posted by niman View Post
                  <a rel="nofollow" href="http://www.recombinomics.com/News/07040901/H274Y_Asymptomatic.html">Commentary</a>
                  Commentary

                  Asymptomatic Traveler With Tamiflu Resistant Pandemic H1N1

                  Recombinomics Commentary 20:20
                  July 4, 2009

                  Asymptomatic

                  Returned from San Francisco with mother and daughter (confirmed patient) on June 11

                  Admitted to United Christian Hospital (UCH) on June 12

                  Imported

                  Singapore Airlines (flight no SQ1) Arrived on June 11

                  Daughter (confirmed patient), mother, two sisters , a brother

                  The above data, from a Hong Kong DOH report describing pandemic H1N1 confirmed cases, is the only entry that<a rel="nofollow" href="http://www.recombinomics.com/News/07030901/H274Y_HK_SF.html"> matches</a> reports on the 16 year old who was intercepted at the airport on June 11 and was subsequently found to be infected with Tamiflu resistant H1N1. The patient's flight had originated in San Francisco, and Singapore Airlines flight SQ1 is a nonstop flight from San Francisco to Hong Kong, providing additional evidence for Tamiflu resistant H1N1 in northern California.

                  The above description indicates the confirmed patient was the daughter in the traveling family described above. The case is also described as asymptomatic, in contrast to media reports which indicated where was identified because of a fever. The cause of the discrepancy remains unclear, although the above report lists the age of the female patient as 36 instead of 16 and admission into United Christian Hospital instead of Queen Mary Hospital although transfer from one hospital to another could explain that discrepancy.

                  In any event, the above description is the only patient listed who flew into Hong Kong from San Francisco on June 11, and likely represents the case who had mild symptoms or was asymptomatic on arrival. Since the patient was not taking Tamiflu, the resistance would represent a fit pandemic H1N1 which is likely circulating in the United States.

                  Currently, <a rel="nofollow" href="http://www.recombinomics.com/News/07030902/H274Y_Swine_Spread.html">efforts</a> in the United States are directed toward severe cases and would likely miss either mild or asymptomatic individuals, allowing for silent spread of Tamiflu resistant pandemic H1N1.

                  The other two reported cases with H274Y (<a rel="nofollow" href="http://www.recombinomics.com/News/06290902/Pandemic_H1N1_Resistance.html">Denmark</a> and Japan) were from patients who were on a prophylactic dose. Although agencies have focused on a <a rel="nofollow" href="http://www.recombinomics.com/News/06290903/H274Y_Swine_Roche.html">spontaneous mutation</a> selected by the Tamiflu treatment, the reports do not exclude a mixture, with the H274Y on a minor population. A mixture would also raise concerns of silent spread of H274Y. The presence of H274Y in a treated patient may also be present in India, where a patient is asymptomatic, but shedding pandemic H1n1 in spite of a full course of Tamiflu treatment. The emergence of H274Y in treatment patients may simply reflect selection of this minor population. However, the presence of H274Y in a minor population could lead to a jump onto another variant of pandemic H1H1, as was seen in seasonal H1N1. The fixing of H274Y in seasonal flu was preceded by H274Y in a number of clades and sub-clades, signaling multiple dependent introductions into hosts not taking Tamiflu.

                  The fixing of H274Y in seasonal flu has led to predictions that pandemic H1N1 with H274Y would emerge due to recombination between seasonal and pandemic H1N1. Others expected such dual infections to lead to acquisition of H274Y by reassortment, but none of the examples describe to date have involved reassortment and acquisition of human N1.

                  The reports of three examples of H274Y this week supports acquisition via recombination, and more such examples are expected in the near term, as more labs focus on H274Y in pandemic H1N1.

                  .
                  "The next major advancement in the health of American people will be determined by what the individual is willing to do for himself"-- John Knowles, Former President of the Rockefeller Foundation

                  Comment

                  • #10
                    Re: Tamiflu Resistant Pandemic H1N1 in Asymptomatic Traveler from San Francisco

                    INFLUENZA A (H1N1) - WORLDWIDE (84): TAMIFLU RESISTANCE, CHINA (HONG
                    KONG S.A.R.)
                    ***********************************************
                    A ProMED-mail post
                    <http://www.promedmail.org>
                    ProMED-mail is a program of the
                    International Society for Infectious Diseases
                    <http://www.isid.org>

                    Date: Sat 4 Jul 2009
                    Source: 660News, All News Radio, The Canadian Press [edited]
                    <http://www.660news.com/news/national/more.jsp?content=n034881128>


                    All cases of Tamiflu resistance are not created equal. So while the
                    1st 3 instances of swine flu infection with Tamiflu-resistant viruses
                    were reported in the past week, it was Number 3, not Number 1 that put
                    influenza experts on edge. Public health authorities in Hong Kong
                    announced Friday [3 Jul 2009] they have found a case of Tamiflu
                    resistance in a woman who hadn't taken the drug. That means she was
                    infected with swine flu viruses that were already resistant to
                    Tamiflu, the main weapon in most countries' and companies' pandemic
                    drug arsenals.

                    The 2 earlier cases, reported from Denmark and Japan, involved people
                    who had been taking the medication. While always unwelcome, that type
                    of resistance is known to occur with seasonal [influenza virus]
                    strains and may be less of a threat to the long-term viability of this
                    key flu drug. "It was not at all surprising to see resistance in
                    patients on treatment, but seeing it in someone who was not treated,
                    it certainly is more concerning," says Dr. Malik Peiris, a flu expert
                    at the University of Hong Kong.

                    There is currently no evidence Tamiflu-resistant viruses are spreading
                    widely. Still, some experts see the Hong Kong case as a warning that
                    Tamiflu's role in this pandemic may not be as long-lived as pandemic
                    planners would like. "I think it's too early to judge," says Dr.
                    Frederick Hayden, an expert on influenza antivirals who teaches at the
                    University of Virginia. "But I think that possibility has existed from
                    the beginning, and it's something that needs to be certainly
                    considered in making determinations about things like antiviral
                    stockpiling, management of patients with more serious illness in
                    hospital and how the available drugs will be used."

                    Some experts say this early sign of resistance should prompt a rethink
                    of how often and in which circumstances Tamiflu is used to battle the
                    novel H1N1 virus. "It ... probably highlights the importance of not
                    using these antiviral drugs indiscriminately, given that the disease
                    is relatively mild," says Peiris, whose hospital monitored the woman
                    who was found to be carrying the resistant virus. "In people who don't
                    have underlying risk factors, they probably should not be treated with
                    Tamiflu, basically."

                    Others suggest countries should limit how often they use the drug to
                    prevent infection, a regimen known as prophylaxis. In prophylaxis,
                    people who've been exposed to the virus are given one pill a day for
                    10 days, compared to the treatment regime of 2 pills a day for 5 days.
                    Some countries, including Canada, have been reserving prophylaxis for
                    people at high risk from this flu, such as pregnant women. But others
                    have taken a different approach, using Tamiflu to try to curb spread
                    of the virus. For instance, Britain has made the drug widely available
                    to contacts of confirmed cases, though it announced this past week it
                    was changing that policy.

                    The World Health Organization is drafting guidance for countries on
                    the use of antivirals. While the WHO advises rather than instructs, it
                    has been stressing that saving these drugs for treatment makes the
                    most sense, says Dr. Keiji Fukuda, the agency's top flu expert. "In
                    general we have been pushing the advice that using these drugs for
                    treatment is definitely the priority use of them," says Fukuda, the
                    acting assistant director general for health security and environment.
                    "And I think this is not just from a theoretical resistance
                    perspective but also from the fact that if you have limited amounts of
                    antiviral drugs, then you need to make some choices about how you use
                    them."

                    From their 1st sighting, the new H1N1 viruses have been resistant to
                    2 older flu drugs, amantadine and rimantadine. That left the only 2
                    other influenza drugs, oseltamivir (Tamiflu) and zanamivir (Relenza),
                    as the sole options for treatment and prophylaxis. There is a risk
                    inherent in using the drug to prevent illness. If people who are
                    already infected but aren't yet experiencing symptoms are put on
                    prophylaxis, there won't be enough drug in their systems to kill all
                    the viruses they house. Those that survive develop resistance to the
                    drug. And that, it appears, may be what happened in the resistance
                    cases in Denmark and Japan. In both instances the women involved had
                    been given Tamiflu prophylaxis after a contact developed swine flu.

                    But the Hong Kong case was different. A 16-year-old girl travelling
                    from San Francisco was stopped in Hong Kong's airport in mid-June
                    [2009] after setting off a fever detection device. She was taken to
                    hospital where she tested positive for swine flu. She had not been
                    taking antivirals and declined to be treated with the drug. She was
                    kept in isolation until she recovered.

                    Dr. Jennifer McKimm-Breschkin, an influenza expert from Australia and
                    a member of the team that developed Relenza, says this case shows
                    resistant swine flu viruses can spread. It was previously thought flu
                    viruses that developed resistance to the drug would be crippled in the
                    process and would not transmit to others. But that belief was
                    shattered in 2008 when it was discovered Tamiflu-resistant versions of
                    the seasonal H1N1 viruses were spreading rapidly around the globe.
                    They have since all but wiped out [replaced] Tamiflu-susceptible
                    seasonal H1N1 viruses. "This is a patient that hasn't been treated who
                    has gone from San Francisco to Hong Kong. What that means is that she
                    has caught a resistant virus in San Francisco," says McKimm-
                    Breschkin, virology project leader at the Commonwealth Science and
                    Research Organization -- known as CSIRO -- in Melbourne. "So that
                    means this virus has been transmitted from somebody who's presumably
                    been treated. Which means it's been fit enough to transmit -- and that
                    is of a lot more concern than just resistance in a treated patient."
                    Experts have worried the seasonal H1N1 viruses might reassort or swap
                    genes with the swine H1N1. If swine flu picked up the neuraminidase
                    gene -- the N in a flu virus' name -- from the seasonal H1N1, it would
                    acquire the resistance its seasonal cousin has developed.

                    Authorities in Hong Kong have not yet told the WHO whether that is
                    what has happened in this case. But whether the Hong Kong resistance
                    case is due to reassortment, or from the fact that some swine flu
                    viruses have developed resistance on their own, the situation demands
                    careful monitoring, Fukuda and others say. "The really big question
                    for any finding of antiviral drug resistance with these viruses is
                    whether it's an isolated event or whether it's a tip of a larger
                    phenomenon," he explains. "The bottom line, as is so often the bottom
                    line with influenza, is that the real answer to the current situation
                    is monitoring as closely as possible, which in this instance is really
                    being done, since an extraordinary number of viruses are being
                    collected and looked at."

                    [Byline: Helen Branswell]

                    --
                    Communicated by:
                    ProMED-mail Rapporteur Mary Marshall

                    [The identification in Hong Kong (S.A.R.) of a patient arriving from
                    the USA harboring Tamiflu-resistant A (H1N1) pandemic influenza virus,
                    who had not previously received Tamiflu treatment, is a disturbing but
                    not unexpected development in view of the often indiscriminate use of
                    the antiviral in some countries. It remains to be seen whether this
                    Tamiflu-resistant virus will be transmitted more or less efficiently
                    than Tamiflu-sensitive virus. It may be that Tamiflu will become
                    largely ineffective in the control and treatment of the A (H1N1)
                    pandemic virus sooner rather than later. Restriction in future use of
                    Tamiflu should be considered.

                    Unlike Tamiflu, which is administered orally in tablet form, the
                    alternate neuraminidase inhibiter Zanamivir (Relenza) is an antiviral
                    that must be administered twice a day in powder form through a special
                    inhaler, with treatment continuing for up to 5 days. This may be an
                    advantage in reducing the indiscriminate use of the drug. Relenza can
                    be used by people over 12 years of age who are known or suspected to
                    have influenza A or influenza B virus infection. - Mod.CP]

                    [see also:
                    Influenza A (H1N1) - worldwide (83): antiviral resistance 20090705.2417
                    Influenza A (H1N1) - worldwide (82): transmission 20090704.2402
                    Influenza A (H1N1) - worldwide (81): epidemic analysis 20090703.2391
                    Influenza A (H1N1) - worldwide (80): Argentina, human to pig 20090701.2376
                    Influenza A (H1N1) - worldwide (79): case count 20090701.2372
                    Influenza A (H1N1) - worldwide (78): Tamiflu resistance, DK 20090630.2359
                    Influenza A (H1N1) - worldwide (76): comments on 1918 virus (03) 20090625.2309
                    Influenza A (H1N1) - worldwide (74): susp. origin 20090624.2303
                    Influenza A (H1N1) - worldwide (73): case count, epidemiology 20090622.2288
                    Influenza A (H1N1) - worldwide (72): case count, epidemiology 20090619.2261
                    Influenza A (H1N1) - worldwide (70): risk factors 20090619.2260
                    Influenza A (H1N1) - worldwide (69): other viral infections 20090618.2254
                    Influenza A (H1N1) - worldwide (68): southern hemisphere 20090618.2253
                    Influenza A (H1N1) - worldwide (65): antivirals in pregnancy 20090616.2224
                    Influenza A (H1N1) - worldwide (64): case count, pandemic 20090616.2221
                    Influenza A (H1N1) - worldwide (62): Egypt, Lebanon 20090611.2150
                    Influenza A (H1N1) - worldwide (62): Egypt, Lebanon 20090611.2150
                    Influenza A (H1N1) - worldwide (60): Egypt (Cairo) 20090608.2117
                    Influenza A (H1N1) - worldwide (59): Worldwide 20090608.2117
                    Influenza A (H1N1) - worldwide (58): USA, Africa 20090607.2109
                    Influenza A (H1N1) - worldwide (57): Brazil, USA 20090605.2090
                    Influenza A (H1N1) - worldwide (55) 20090603.2056
                    Influenza A (H1N1) - worldwide (47): China, epidemiology 20090526.1962
                    Influenza A (H1N1) - worldwide (45) 20090525.1951
                    Influenza A (H1N1) - worldwide (42) 20090523.1929
                    Influenza A (H1N1) - worldwide (39) 20090521.1903
                    Influenza A (H1N1) - worldwide (37) 20090520.1893
                    Influenza A (H1N1) - worldwide (34) 20090518.1863
                    Influenza A (H1N1) - worldwide (31) 20090516.1835
                    Influenza A (H1N1) - worldwide (29) 20090515.1824
                    Influenza A (H1N1) - worldwide (26) 20090514.1798
                    Influenza A (H1N1) - worldwide (23) 20090511.1764
                    Influenza A (H1N1) - worldwide (21) 20090510.1749
                    Influenza A (H1N1) - worldwide (19) 20090509.1733
                    Influenza A (H1N1) - worldwide (17) 20090508.1722
                    Influenza (H1N1) - worldwide (15) 20090507.1709
                    Influenza A (H1N1) - worldwide (13) 20090506.1695
                    Influenza A (H1N1) - worldwide (11): coincident H3N2 variation 20090505.1679
                    Influenza A (H1N1) - worldwide 20090430.1636
                    Influenza A (H1N1) "swine flu": worldwide (07), update, pandemic 5
                    20090429.1622
                    Influenza A (H1N1) "swine flu": Worldwide 20090427.1583
                    Influenza A (H1N1) virus, human: worldwide 20090426.1577
                    Influenza A (H1N1) virus, human - New Zealand, susp 20090426.1574
                    Influenza A (H1N1) virus, human - N America (04) 20090426.1569
                    Influenza A (H1N1) virus, human - N America 20090425.1552
                    Acute respiratory disease - Mexico, swine virus susp 20090424.1546
                    Influenza A (H1N1) virus, swine, human - USA (02): (CA, TX) 20090424.1541
                    Influenza A (H1N1) virus, swine, human - USA: (CA) 20090422.1516
                    Influenza A (H1N1) virus, swine, human - Spain 20090220.0715]
                    .................................................. .........cp/msp/jw

                    Comment

                    • #11
                      Re: Tamiflu Resistant Pandemic H1N1 in Asymptomatic Traveler from San Francisco

                      Originally posted by niman View Post
                      INFLUENZA A (H1N1) - WORLDWIDE (84): TAMIFLU RESISTANCE, CHINA (HONG
                      KONG S.A.R.)
                      ***********************************************
                      It remains to be seen whether this
                      Tamiflu-resistant virus will be transmitted more or less efficiently
                      than Tamiflu-sensitive virus. cp/msp/jw
                      More lessons NOT learned.

                      Comment

                      • #12
                        Re: Tamiflu Resistant Pandemic H1N1 in Asymptomatic Traveler from San Francisco

                        Originally posted by niman View Post
                        More lessons NOT learned.
                        Does this statement indicate that you think that they will not ration tamiflu effectively to minimize encouraging further resistance or is there another action you think they need to take in light of the seasonal flu resistance experience?

                        It seems like, until we find a foolproof mechanism that we can raise a med against that can not be side stepped by the pathogen, resistance (esp in flu) is a high likelihood at some point, no?
                        Nika

                        Comment

                        • #13
                          Re: Tamiflu Resistant Pandemic H1N1 in Asymptomatic Traveler from San Francisco

                          Welcome Nika!

                          Comment

                          • #14
                            Re: Tamiflu Resistant Pandemic H1N1 in Asymptomatic Traveler from San Francisco

                            Florida:

                            Goodness your fast! Thanks for the lovely welcome! Have learned a lot in cruising here, about time I registered.

                            Nika

                            Comment

                            • #15
                              Re: Tamiflu Resistant Pandemic H1N1 in Asymptomatic Traveler from San Francisco

                              Originally posted by Nika View Post
                              Does this statement indicate that you think that they will not ration tamiflu effectively to minimize encouraging further resistance or is there another action you think they need to take in light of the seasonal flu resistance experience?

                              It seems like, until we find a foolproof mechanism that we can raise a med against that can not be side stepped by the pathogen, resistance (esp in flu) is a high likelihood at some point, no?
                              A fit pandemic H1N1 with H274Y virtially ensures that resistance will spread, and widespread Tamiflu use will accellerate that spread.

                              Comment

                              Previous 1 2 template Next
                              Working...
                              X